Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Kuesis

Sports Medicine Elk Grove Village, IL Medical Doctor

NPI 1679573240 CMS profile 667248

555 Biesterfield Rd, Elk Grove Village, IL 60007

Open in the dashboard

General payments

$10,980

64 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Kuesis of Elk Grove Village, IL is reported in the CMS Open Payments database as having received $10,980 across 64 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $113 5
2024 General $100 3
2023 General $295 4
2022 General $2,706 16
2021 General $1,869 4
2020 General $236 7
2019 General $5,663 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Kuesis
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Daniel Kuesis were reported at $113. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Daniel Kuesis Sports Medicine median Middle half National median
2019 $5,663 $1,176 $199–$4,249 $163
2020 $236 $708 $96–$2,890 $114
2021 $1,869 $1,213 $152–$3,994 $132
2022 $2,706 $1,230 $159–$3,998 $149
2023 $295 $584 $146–$2,836 $160
2024 $100 $628 $163–$3,168 $164
2025 $113 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $6,945 14 payments
  2. Stryker Corporation $2,885 16 payments
  3. Zimmer Biomet Holdings, Inc. $236 4 payments
  4. Linvatec Corporation $132 2 payments
  5. DePuy Synthes Sales Inc. $124 1 payment
  6. Djo, LLC $99 1 payment
  7. Davol Inc. $93 1 payment
  8. Horizon Therapeutics plc $92 6 payments
  9. Heraeus Medical, LLC. $66 4 payments
  10. Heron Therapeutics, Inc. $53 2 payments
  11. Other $255 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,640 4 payments
  2. Travel and Lodging $2,264 8 payments
  3. Food and Beverage $1,977 51 payments
  4. Debt forgiveness $99 1 payment
Products named General payments · program years 2019–2025
  1. VISIONAIRE Digital Templating $3,320 2 payments
  2. Anthology Recon Hips $3,320 2 payments
  3. MAKO $2,510 12 payments
  4. BIRMINGHAM HIP $1,660 1 payment
  5. ANTHOLOGY Recon Hips $1,660 1 payment
  6. JOURNEY II BCS $1,660 1 payment
  7. JOURNEY II CR $1,660 1 payment
  8. JOURNEY II UK $1,660 1 payment
  9. POLARSTEM $1,660 1 payment
  10. POLARCUP $1,660 1 payment
  11. Other $7,121 58 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 18 drugs

Part D claims

1,546

Median for Orthopedic Surgery: 203

Drug cost

$19,196

Median for Orthopedic Surgery: $1,433

Branded share of claims

21.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 316 $5,468
Xarelto Rivaroxaban Brand 11 $4,767
Eliquis Apixaban Brand 18 $3,010
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 238 $2,366
Methylprednisolone Generic 243 $1,159
Mupirocin Generic 61 $486
Cephalexin Generic 240 $392
Famotidine Generic 119 $379
Lansoprazole Generic 18 $298
Ondansetron Odt Ondansetron Brand 29 $294

The 10 drugs with the highest cost, of 18 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 97 billing codes

Paid by Medicare

$933,067

Of which drugs: $182,828

Medicare patients

1,244

Average age 75

Services billed

48,025

793 women, 451 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 34%
Diabetes 27%
Chronic kidney disease 21%
Atrial fibrillation 19%
Depression 19%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg J7329 Office 322 31,175 $176,454
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 854 6,015 $4,604
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose J7321 Office 11 40 $1,393
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 59 345 $98
Injection, lidocaine hcl for intravenous infusion, 10 mg J2001 Office 549 2,049 $19

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

64 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record